Overall, PCNA protein expression in Rosuvastatin and DFMO treatment groups and low dose combination groups showed a significant decrease compared to untreated colon tumors (Fig. 1C, p < 0.002). The gene discussed is PCNA; the disease is colonic neoplasm.